In patients with hyperinsulinemia, an increased expression of tumor markers such as the proto-oncogenes: human epidermal growth factor receptor-2 (HER-2) and B-cell lymphoma-2 (Bcl2), were identified; meanwhile, tumor suppressor gene p53 was significantly decreased [10,14]. The gene discussed is ERBB2; the disease is hyperinsulinism.